Novel Drugs and Smart Devices for Respiratory Disorders, 2018 - 2030
Steffan98705 Jul, 2021Health
Around 135 novel drug candidates are being evaluated across various stages of development for the treatment of patients suffering from asthma, COPD and cystic fibrosis. Of these, around 15 drugs have received approval / market authorization, and 72% and 17% of the candidates are being developed in clinical and preclinical stages, respectively.
Related Bookmarks
- Cybersecurity in Healthcare, 2018-2030
- Gellan Gum has important role in variety of cosmetics, pharmaceuticals, and cosmetics
- Back of the Eye Disorders: Novel Drugs and Delivery Technologies, 2017-2030
- Effective Remedies to Cure Scleroderma Naturally
- Cancer Stem Cell Therapies Market, 2017-2030
- Glycated Albumin Assay is the First-ever Test to Measure and Evaluate the Total Glycated Albumin Pre
- Demand for Geriatric Care Services Has Increased Due to Growing Geriatric Population
- Gastroscopy devices has become essential in the diagnosis of mucosal disorders of the gastrointestin
- Eldershield Assessment
- Gamma Knife Surgery Process Is a Kind of Radiation Therapy, Which Is Used To Various Abnormalities i
Recent Profiles
Ceo Matt Wilson
33agid Id
Rainbowrichesp
Hargatoto Situs Game Online
Nhà Cái Mu88
Marta
Pankaj Tripathi
123b
Bet88
Rikvip